期刊文献+

泰利霉素重要中间体3-氧代-6-O-甲基红霉素的合成 被引量:1

Synthesis of 3-Oxo-6-O-methylerythromycin,an Important Intermediate of Telithromycin
下载PDF
导出
摘要 由克拉霉素的前体6-O-甲基-2′,4″-二(三甲基硅)-红霉素A9-(1-异丙氧基环己基)肟(Ⅰ)出发,常温下以φ(HC l)=10%的盐酸催化水解得3-羟基-6-O-甲基红霉素A9肟(Ⅱ);然后一锅煮进行化合物Ⅱ的2′-羟基乙酰化、3-羟基氧化,得2′-乙酰基-3-氧代-6-O-甲基红霉素A9-(O-乙酰基)肟(Ⅳ);最后脱乙酰基、还原9-肟基再次应用一锅煮法合成,得到目的化合物3-氧代-6-O-甲基红霉素(Ⅵ),总收率为57.0%,经HPLC测定w(Ⅵ)=98.5%。通过1HNMR1、3CNMR和MS,表征了各中间体及目标化合物的结构。 Hydrolysis of 6-O-methyl-2' ,4"-bis ( trimethylsilyl ) -erythromycin A9- ( isopropoxycyclohexyl ) oxime ,a precursor of clarithromycin, was conducted under φ (HCI) = 10% hydrochloric acid as a catalyst at room temperature for 2 h to yield 3-hydroxy-6-O-methylerythromycin A9-oxime. Then 2'-OH was protected with acetyl group and 3-OH was oxidized in one-pot synthesis to yield 2'-O-acetyl-3-oxo- 6-O-methylerythromycin A9-acetyloxime. Finally two acetyl groups were removed and 9-oxime was reduced in one-pot synthesis. 3-Oxo-6-O-methylerythromycin was obtained in 57.0% overall yield with 98.5% purity. Structures of the target compound and all intermediates were identified by ^1HNMR, ^13CNMR and MS.
出处 《精细化工》 EI CAS CSCD 北大核心 2007年第7期678-680,共3页 Fine Chemicals
基金 国家经贸委技术创新项目(01BK-009)~~
关键词 3-氧代-6-O-甲基红霉素 泰利霉素 一锅煮 医药原料 3 -oxo-6 -O-methylerythromycin telithromycin one-pot synthesis drug materials
  • 相关文献

参考文献6

  • 1Julia A,David P.Telithromycin[J].Drugs,2001,61(6):815-829.
  • 2Chu D,Burger M,Lin X,et al.C12 modified erythromycin macrolides and ketolides having antibacterial activity[P].WO:03 004 509,2003-01-16.
  • 3Kashimura M,Asaka T,Misawa Y,et al.Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs[J].J Antibiot,2001,54(8):664-678.
  • 4Agouridas C,Denis A,Auger J,et al.Synthesis and antibacterial activity of ketolides(6-O-methyl-3-O-oxoerythromycin derivatives):a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens[J].J Med Chem,1998,41:4080-4100.
  • 5Zhao Ying,You Qidong,Shen Wenbin.A novel bicyclic ketolide derivative[J].J Bioorg Med Chem Lett,2003,13:1805-1807.
  • 6梁建华,姚国伟.克拉霉素的合成新方法[J].有机化学,2005,25(4):438-441. 被引量:7

二级参考文献4

共引文献6

同被引文献10

  • 1梁建华,姚国伟.克拉霉素的合成新方法[J].有机化学,2005,25(4):438-441. 被引量:7
  • 2孟涛,庞思平,姚国伟,庄洁,黄成.3-羟基-6-O-甲基红霉素的合成优化与副产物的分析[J].化学研究,2006,17(4):38-40. 被引量:6
  • 3杨翠,庞思平,庄洁,曲运波.3-OH克拉霉素及其副产物的谱图解析与结构鉴定[J].光谱实验室,2007,24(3):460-462. 被引量:1
  • 4Chu,D T. Recent developments in macrolides and ketolides [ J ]. Curr Opin Microbiol, 1999,2(5 ) :467 -474.
  • 5Asaka T, Manaka A, Sugiyama H. Recent developments in macrolide antimicrobial research[ J]. Curr Top Med Chem,2003,3 (9) :961 -989.
  • 6Blasi F, Farrell D J, Dubreuil L. Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the prospective resistant organism tracking and epidemiology for the ketolide telithromycin study year 5 ( 2003 - 2004 ) [ J ]. Diagn Microbiol Infect Dis ,2009,63 ( 3 ) :302 - 308.
  • 7Hunter P A. Keolides-a novel form of macrolide: the way forward? [ J ]. Drug Discovery Today, 1998,3 (6) :257 - 260.
  • 8Denis A, Agouridas C, Auger J M, et al. Synthesis and antibacterial activity of HMR 3647, A new ketolide, highly potent against resistant and susceptible respiratory pathogens [ J ]. Bioorg Med Chem Lett, 1999,99 ( 21 ) : 3075 - 3080.
  • 9Kaneko T, McMillen W, Lynch M K. Synthesis and antibacterial activity of C11 ,C12-cyclic urea analogues of ketolides[ J]. Bioorg Med Chem Lett,2007,17(18) :5013 -5018.
  • 10Wei X, You Q D. A facile and scaleable synthesis of 3-O- decladinnose-6 -methyl- 10,11 -dehydrate-erythromycin-3-one-2'- acetate,an important intermediate for ketolide synthesis[ J]. Org Process Res Dev ,2006,10 ( 3 ) :446 - 449.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部